Acitretin Capsule
Product Images NDC 42291-086

5 FDA label images from Avkare · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Acitretin (NDC 42291-086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg (Screen Shot 2017 10 11 At 2.59.40 Pm)

10mg (Screen Shot 2017 10 11 At 2.59.40 Pm)
ACITRETIN Capsules USP 10 mg by AvKARE, an oral human prescription drug. The label shows a 30-capsule bottle with warnings including causing birth defects and instructions to keep out of reach of children. It also states storage conditions and pharmacist dispensing guidance, along with barcode and labeler information.*
FDA Label Image

17.5mg (Screen Shot 2017 10 11 At 3.00.04 Pm)

17.5mg (Screen Shot 2017 10 11 At 3.00.04 Pm)
Acitretin Capsules, USP 17.5 mg oral capsules packaging label by AvKARE. The label states the medication is prescription only, with warnings not to crush, break, or get pregnant while taking the drug. It contains 30 capsules and includes storage and safety instructions for pharmacists and patients.*
FDA Label Image

25mg (Screen Shot 2017 10 11 At 3.00.24 Pm)

25mg (Screen Shot 2017 10 11 At 3.00.24 Pm)
Acitretin Capsules, USP 25 mg oral capsules packaged by AvKARE. The label indicates a quantity of 30 capsules and highlights a warning that the drug causes birth defects and that pharmacists should dispense the accompanying Medication Guide. The label includes storage instructions and manufacturer details for AvKARE, Inc.*
FDA Label Image

Structure (Mm1)

Structure (Mm1)
Chemical structure diagram of acitretin, showing its molecular arrangement with multiple methyl groups, double bonds, a carboxylic acid group, and a methoxy substituent on the aromatic ring.*
FDA Label Image

Birth Defects (Mm2)

Birth Defects (Mm2)
A warning graphic showing a silhouette of a pregnant woman inside a red prohibition circle, accompanied by the text 'CAUSES BIRTH DEFECTS' above and 'DO NOT GET PREGNANT' below the image. This illustrates a strong caution regarding pregnancy risks associated with the drug Acitretin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.